DK2072041T3 - Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof - Google Patents

Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof

Info

Publication number
DK2072041T3
DK2072041T3 DK08462008.7T DK08462008T DK2072041T3 DK 2072041 T3 DK2072041 T3 DK 2072041T3 DK 08462008 T DK08462008 T DK 08462008T DK 2072041 T3 DK2072041 T3 DK 2072041T3
Authority
DK
Denmark
Prior art keywords
preparation
film
active substance
coated tablets
tablets containing
Prior art date
Application number
DK08462008.7T
Other languages
English (en)
Inventor
Attila Bodis
Istvan Greiner
Kasza Jonathan Mihaly Nagy
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of DK2072041T3 publication Critical patent/DK2072041T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK08462008.7T 2007-12-20 2008-10-06 Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof DK2072041T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0700826A HUP0700826A3 (en) 2007-12-20 2007-12-20 Coated tablet containing drospirenone and process for producing the same

Publications (1)

Publication Number Publication Date
DK2072041T3 true DK2072041T3 (da) 2012-11-05

Family

ID=89987951

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08462008.7T DK2072041T3 (da) 2007-12-20 2008-10-06 Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof

Country Status (23)

Country Link
US (1) US20110002993A1 (da)
EP (2) EP2072041B1 (da)
JP (1) JP5679819B2 (da)
CN (1) CN101896166B (da)
AU (1) AU2008339588B2 (da)
BR (1) BRPI0820450A2 (da)
CA (1) CA2708875A1 (da)
CY (1) CY1113416T1 (da)
DK (1) DK2072041T3 (da)
EA (1) EA017869B1 (da)
ES (1) ES2391953T3 (da)
HK (1) HK1147054A1 (da)
HR (1) HRP20120815T1 (da)
HU (1) HUP0700826A3 (da)
IL (1) IL205818A (da)
MY (1) MY148138A (da)
NZ (1) NZ585554A (da)
PL (1) PL2072041T3 (da)
PT (1) PT2072041E (da)
SI (1) SI2072041T1 (da)
UA (1) UA103182C2 (da)
WO (1) WO2009081216A1 (da)
ZA (1) ZA201003913B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160048305A1 (en) * 2014-08-14 2016-02-18 Microsoft Corporation Group-Based User Interface Rearrangement
US10232045B2 (en) * 2016-08-04 2019-03-19 Bpsi Holdings Llc Easy to swallow coatings and substrates coated therewith
WO2019146788A1 (ja) * 2018-01-29 2019-08-01 Phcホールディングス株式会社 バイオセンサプローブ用保護膜材料
EP3766421A4 (en) * 2018-03-13 2021-12-15 PHC Holdings Corporation PROTECTIVE FILM MATERIAL FOR BIOSENSOR PROBE

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
DK1598069T3 (da) * 1999-08-31 2009-07-06 Bayer Schering Pharma Ag Farmaceutisk præparat af ethinylestradiol og drospirenon til anvendelse som præventionsmiddel
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
JP2004315713A (ja) * 2003-04-18 2004-11-11 Shin Etsu Chem Co Ltd 非イオン性セルロースエーテルの製造方法及びこれにより得られる非イオン性セルロースエーテル造粒物
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
US8475838B2 (en) * 2005-06-03 2013-07-02 Sandoz Ag Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
EP1767194A1 (de) * 2005-06-09 2007-03-28 Helm AG Verfahren zur Herstellung von Adsorbaten des Drospirenons

Also Published As

Publication number Publication date
UA103182C2 (ru) 2013-09-25
JP2011507825A (ja) 2011-03-10
PL2072041T3 (pl) 2012-12-31
HUP0700826A3 (en) 2010-03-29
AU2008339588A1 (en) 2009-07-02
JP5679819B2 (ja) 2015-03-04
CY1113416T1 (el) 2016-06-22
CA2708875A1 (en) 2009-07-02
ZA201003913B (en) 2011-03-30
NZ585554A (en) 2012-06-29
EP2446880A1 (en) 2012-05-02
IL205818A (en) 2016-05-31
CN101896166A (zh) 2010-11-24
US20110002993A1 (en) 2011-01-06
MY148138A (en) 2013-02-28
AU2008339588B2 (en) 2014-06-26
HRP20120815T1 (hr) 2012-11-30
SI2072041T1 (sl) 2012-11-30
IL205818A0 (en) 2010-11-30
ES2391953T3 (es) 2012-12-03
EP2072041A1 (en) 2009-06-24
HK1147054A1 (en) 2011-07-29
PT2072041E (pt) 2012-10-31
HUP0700826A2 (en) 2009-07-28
WO2009081216A1 (en) 2009-07-02
EP2072041B1 (en) 2012-08-01
EA201001032A1 (ru) 2010-12-30
CN101896166B (zh) 2013-05-01
EA017869B1 (ru) 2013-03-29
HU0700826D0 (en) 2008-02-28
BRPI0820450A2 (pt) 2015-06-16

Similar Documents

Publication Publication Date Title
DK2346888T3 (da) Fremgangsmåde til fremstilling af som SGLT-inhibitorer anvendelige forbindelser
DK2431359T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2344198T3 (da) Lipidbaserede farmaceutiske præparater til topisk anvendelse
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
NO20090295L (no) Substituerte heteroarylderivater
CL2007001040A1 (es) Proceso para la preparacion de antagonista de la sustancia p derivado de acil-amino-alquilen-amida.
DK2462116T3 (da) Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
HK1160762A1 (zh) 料盒、用於固體藥物部分的藥物分配器以及它們的使用
PL2076244T3 (pl) Układy wodne do wytwarzania związków farmaceutycznych na bazie lipidów; kompozycje, sposoby, oraz ich zastosowanie
DK2773633T3 (da) Heterocykliske forbindelser, medikamenter indeholdende forbindelserne, anvendelse deraf og fremgangsmåder til fremstilling deraf.
BRPI0906475A2 (pt) Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
MY162411A (en) Crystalline forms of a macrolide, and uses therefor
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
DK2658851T3 (da) Heterocykliske forbindelser, som er egnede til behandling af dyslipidæmi
DK2107055T3 (da) Dosmetinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
AP2011005935A0 (en) New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them.
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
UA107476C2 (uk) Фармацевтична субстанція на основі мітохондріально адресованих антиоксидантів
DK1843977T3 (da) Fremgangsmåde til fremstilling af cæsiumhydroxidopløsninger
DK2281822T3 (da) Nye dihydroindolonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger, som indeholder disse
DK2231598T3 (da) Nye diazeniumdiolatderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
DK2471781T3 (da) Benzylaralkylether-forbindelser, fremgangsmåde til fremstilling af samme, mel-lemproduktforbindelser, anvendelse af disse forbindelser, fremgangsmåde til behandling og/eller forebyggelse, farmaceutisk sammensætning og medikament, som indeholder samme.
DK2072041T3 (da) Fremgangsmåde til fremstilling af filmovertrukne tabletter, derindeholder drospirenon som aktivt stof
BRPI1006758A2 (pt) compostos fosfocálcicos dopados com gálio, processos em estado sólido e em solução para a fabricação de um composto fosfocálcico dopado com gálio e uso de um composto fosfocálcico dopado com gálio